AI-generated summary
The authors vaccinated Kunming mice with lysate from photodynamic therapy-treated H22 liver cancer cells, then challenged them with liver tumor cells. They report that the vaccine increased CD4, CD8 and CD19 cell percentages, slowed tumor growth and prolonged survival, and suggest possible adjuvant use. These findings come from an animal study.
- Who or what was studied
- Kunming mice with H22 liver cancer tumor model
- Limits stated in the abstract
- The study is a preclinical animal study, and the abstract does not report the sample size or clinical testing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.